Ratio Therapeutics

0 followers

‌

A discovery through early clinical phase pharmaceutical company, Ratio Therapeutics employs a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancer.

Industries

Biotechnology, Pharmaceutical

Headquarters

Boston, United States

Employees

11-50

Links

Org chart

Jack Hoppin

Chairman & CEO

Jack Hoppin

Collapse

John Babich

Director, President, & Chief Scientific Officer

Shawn Hillier

COO

Jacob Hesterman

Chief Data Officer

John M. Garvey

Chief Legal Officer & General Counsel

Matthias Friebe

Chief Technology Officer

Stephen Dimagno

Head, Chemistry

Kelly Orcutt

Head, Pharmacology

Allan Green

Director & Regulatory Consultant

Susan K. Whoriskey

Director

Bill Cupelo

Chief Business Officer

Robyn T.

Financal Operations Specialist

Teams

Scientific Research Team

10 members

Leadership Team

8 members

Operations Team

5 members

Data and Technology Team

4 members

Similar companies

Immunome

2 followers

BeiGene

19 followers

Catalent

17 followers

Abbott

277 followers

Tessera Therapeutics

2 followers

Ventyx Biosciences

1 follower

Pyxis Oncology

1 follower

Mineralys Therapeutics

1 follower

Thrive Capital

26 followers

Vial

5 followers

aescape

6 followers

Explore companies